Zhejiang Haisheng Pharmaceutical

Zhejiang Haisheng Pharmaceutical Co., Ltd. is a high-tech enterprise focused on the research, development, production, and sale of active pharmaceutical ingredients (APIs) and intermediates for both veterinary and human use. Founded in October 2007 as Zhejiang Haisheng Chemical Co., Ltd., the company is located in Quzhou, Zhejiang province. The company's legal representative, Chairman, and General Manager is Ye Shanhai, who has over thirty years of experience in the pharmaceutical industry, including a previous role as deputy director at Juhua Group Corporation Pharmaceutical Factory.

The company's core business revolves around the production of sulfa-based APIs, boasting a comprehensive industrial chain for these products. Its main products include veterinary APIs targeting microbial and parasitic diseases, and human APIs for antipyretic, analgesic, and antibacterial applications. Zhejiang Haisheng Pharmaceutical has established a significant R&D presence with a 3,000-square-meter provincial-level research center to focus on process optimization and new product development. Its products have secured numerous certifications, including Good Manufacturing Practice (GMP) certificates, European Pharmacopoeia (CEP) certificates, and approvals from authorities in Japan (MF), and Australia (TGA).

Zhejiang Haisheng Pharmaceutical went public on the Beijing Stock Exchange (BSE) on February 2, 2024, under the stock code 870656. The IPO was managed by Changjiang Securities. Before the IPO, Ye Shanhai and his daughter, Ye Jinzhi, were the controlling shareholders and acted in concert. The company operates in both domestic and international markets, selling its products to a global client base.

Keywords: active pharmaceutical ingredients, veterinary APIs, human APIs, sulfa drugs, GMP certified, pharmaceutical manufacturing, intermediates, antimicrobial, antipyretic, analgesic, Beijing Stock Exchange, Zhejiang Haisheng, Ye Shanhai, drug development, chemical synthesis, public company, pharmaceutical exports, animal health, China pharmaceuticals, Quzhou